|
1
|
Chen J, Fang X, Dang X, Wu X and Yi Z:
Association of the paired box 2 gene polymorphism with the
susceptibility and pathogenesis of Henoch-Schönlein Purpura in
children. Mol Med Rep. 11:1997–2003. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Leung AKC, Barankin B and Leong KF:
Henoch-Schönlein Purpura in Children: An updated review. Curr
Pediatric Rev. 16:265–276. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pillebout E and Sunderkotter C: IgA
vasculitis. Semin Immunopathol. 43:729–738. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Oni L and Sampath S: Childhood IgA
vasculitis (Henoch Schonlein Purpura)-advances and knowledge gaps.
Front Pediatr. 7:2572019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xie B, Zhang W, Zhang Q, Zhang Q, Wang Y,
Sun L, Liu M and Zhou P: An integrated transcriptomic and proteomic
analysis identifies significant novel pathways for Henoch-Schönlein
Purpura nephritis progression. Biomed Res Int. 2020:24891752020.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gao R, Niu X, Zhu L, Qi R and He L: iTRAQ
quantitative proteomic analysis differentially expressed proteins
and signal pathways in Henoch-Schönlein Purpura nephritis. Am J
Transl Res. 12:7908–7922. 2020.PubMed/NCBI
|
|
7
|
Fang X, Wu H, Lu M, Cao Y, Wang R, Wang M,
Gao C and Xia Z: Urinary proteomics of Henoch-Schönlein Purpura
nephritis in children using liquid chromatography-tandem mass
spectrometry. Clin Proteomics. 17:102020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Naderi AS and Reilly RF: Primary care
approach to proteinuria. J Am Board Fam Med. 21:569–574. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Taherkhani A, Farrokhi Yekta R, Mohseni M,
Saidijam M and Arefi Oskouie A: Chronic kidney disease: A review of
proteomic and metabolomic approaches to membranous
glomerulonephritis, focal segmental glomerulosclerosis, and IgA
nephropathy biomarkers. Proteome Sci. 17:72019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li J, Smith LS and Zhu HJ:
Data-independent acquisition (DIA): An emerging proteomics
technology for analysis of drug-metabolizing enzymes and
transporters. Drug discovery today. Technologies. 39:49–56.
2021.PubMed/NCBI
|
|
11
|
Demichev V, Szyrwiel L, Yu F, Teo GC,
Rosenberger G, Niewienda A, Ludwig D, Decker J, Kaspar-Schoenefeld
S, Lilley KS, et al: dia-PASEF data analysis using FragPipe and
DIA-NN for deep proteomics of low sample amounts. Nat Commun.
13:39442022. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mun DG, Vanderboom PM, Madugundu AK,
Garapati K, Chavan S, Peterson JA, Saraswat M and Pandey A:
DIA-based proteome profiling of nasopharyngeal Swabs from COVID-19
patients. J Proteome Res. 20:4165–4175. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ozen S, Pistorio A, Iusan SM, Bakkaloglu
A, Herlin T, Brik R, Buoncompagni A, Lazar C, Bilge I, Uziel Y, et
al: EULAR/PRINTO/PRES criteria for Henoch-Schönlein Purpura,
childhood polyarteritis nodosa, childhood Wegener granulomatosis
and childhood Takayasu arteritis: Ankara 2008. Part II: Final
classification criteria. Ann Rheum Dis. 69:798–806. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Parker SJ, Rost H, Rosenberger G, Collins
BC, Malmström L, Amodei D, Venkatraman V, Raedschelders K, Van Eyk
JE and Aebersold R: Identification of a set of conserved eukaryotic
internal retention time standards for data-independent acquisition
mass spectrometry. Mol Cell Proteomics. 14:2800–2813. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Meier F, Brunner AD, Koch S, Koch H,
Lubeck M, Krause M, Goedecke N, Decker J, Kosinski T, Park MA, et
al: Online parallel accumulation-serial fragmentation (PASEF) with
a novel trapped ion mobility mass spectrometer. Mol Cell
Proteomics. 17:2534–2545. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gotz S, Garcia-Gomez JM, Terol J, Williams
TD, Nagaraj SH, Nueda MJ, Robles M, Talón M, Dopazo J and Conesa A:
High-throughput functional annotation and data mining with the
Blast2GO suite. Nucleic Acids Res. 36:3420–3435. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kanehisa M, Goto S, Sato Y, Furumichi M
and Tanabe M: KEGG for integration and interpretation of
large-scale molecular data sets. Nucleic Acids Res. 40:D109–D114.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Szklarczyk D, Franceschini A, Wyder S,
Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos
A, Tsafou KP, et al: STRING v10: Protein-protein interaction
networks, integrated over the tree of life. Nucleic Acids Res.
43:D447–D452. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen JY and Mao JH: Henoch-Schönlein
Purpura nephritis in children: Incidence, pathogenesis and
management. World J Pediatr. 11:29–34. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mucha K, Bakun M, Jazwiec R, Dadlez M,
Florczak M, Bajor M, Gala K and Pączek L: Complement components,
proteolysisrelated, and cell communicationrelated proteins detected
in urine proteomics are associated with IgA nephropathy. Pol Arch
Med Wewn. 124:380–386. 2014.PubMed/NCBI
|
|
21
|
Surin B, Sachon E, Rougier JP, Steverlynck
C, Garreau C, Lelongt B, Ronco P and Piedagnel R: LG3 fragment of
endorepellin is a possible biomarker of severity in IgA
nephropathy. Proteomics. 13:142–152. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Neprasova M, Maixnerova D, Novak J, Reily
C, Julian BA, Boron J, Novotny P, Suchanek M, Tesar V and Kacer P:
Toward noninvasive diagnosis of IgA nephropathy: A Pilot urinary
metabolomic and proteomic study. Dis Markers. 2016:36509092016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guo Z, Wang Z, Lu C, Yang S, Sun H, Reziw,
Guo Y, Sun W and Yue H: Analysis of the differential urinary
protein profile in IgA nephropathy patients of Uygur ethnicity. BMC
Nephrol. 19:3582018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rocchetti MT, Papale M, d'Apollo AM,
Suriano IV, Di Palma AM, Vocino G, Montemurno E, Varraso L,
Grandaliano G, Di Paolo S and Gesualdo L: Association of urinary
laminin G-like 3 and free K light chains with disease activity and
histological injury in IgA nephropathy. Clin J Am Soc Nephrol.
8:1115–1125. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
He Q, Shao L, Yu J, Ji S, Wang H, Mao Y
and Chen J: Urinary proteome analysis by matrix-assisted laser
desorption/ionization time-of-flight mass spectrometry with
magnetic beads for identifying the pathologic presentation of
clinical early IgA nephropathy. J Biomed Nanotechnol. 8:133–139.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Taylor S, Pieri K, Nanni P, Tica J,
Barratt J and Didangelos A: Phosphatidylethanolamine binding
protein-4 (PEBP4) is increased in IgA nephropathy and is associated
with IgA-positive B-cells in affected kidneys. J Autoimmun.
105:1023092019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rudnicki M, Siwy J, Wendt R, Lipphardt M,
Koziolek MJ, Maixnerova D, Peters B, Kerschbaum J, Leierer J,
Neprasova M, et al: Urine proteomics for prediction of disease
progression in patients with IgA nephropathy. Nephrol Dial
Transplant. 37:42–52. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ning X, Yin Z, Li Z, Xu J, Wang L, Shen W,
Lu Y, Cai G, Zhang X and Chen X: Comparative proteomic analysis of
urine and laser microdissected glomeruli in IgA nephropathy. Clin
Exp Pharmacol Physiol. 44:576–585. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Turnier JL, Brunner HI, Bennett M, Aleed
A, Gulati G, Haffey WD, Thornton S, Wagner M, Devarajan P, Witte D,
et al: Discovery of SERPINA3 as a candidate urinary biomarker of
lupus nephritis activity. Rheumatology (Oxford). 58:321–330. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cai Z, Zhang S, Wu P, Ren Q, Wei P, Hong
M, Feng Y, Wong CK, Tang H and Zeng H: A novel potential target of
IL-35-regulated JAK/STAT signaling pathway in lupus nephritis. Clin
Transl Med. 11:e3092021. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Varghese SA, Powell TB, Budisavljevic MN,
Oates JC, Raymond JR, Almeida JS and Arthur JM: Urine biomarkers
predict the cause of glomerular disease. J Am Soc Nephrol.
18:913–922. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
He X, Yin W, Ding Y, Cui SJ, Luan J, Zhao
P, Yue X, Yu C, Laing X and Zhao Y: Higher serum angiotensinogen is
an indicator of IgA vasculitis with nephritis revealed by
comparative proteomes analysis. PLoS One. 10:e01305362015.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schmitt R: ZAG-a novel biomarker for
cardiovascular risk in ESRD patients? Kidney Int. 94:858–860. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sörensen-Zender I, Beneke J, Schmidt BM,
Menne J, Haller H and Schmitt R: Zinc-alpha2-glycoprotein in
patients with acute and chronic kidney disease. BMC Nephrol.
14:1452013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Soggiu A, Piras C, Bonizzi L, Hussein HA,
Pisanu S and Roncada P: A discovery-phase urine proteomics
investigation in type 1 diabetes. Acta Diabetol. 49:453–464. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Somparn P, Hirankarn N, Leelahavanichkul
A, Khovidhunkit W, Thongboonkerd V and Avihingsanon Y: Urinary
proteomics revealed prostaglandin H(2)D-isomerase, not
Zn-alpha2-glycoprotein, as a biomarker for active lupus nephritis.
J Proteomics. 75:3240–3247. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ekman R, Johansson BG and Ravnskov U:
Renal handling of Zn-alpha2-glycoprotein as compared with that of
albumin and the retinol-binding protein. J Clin Invest. 57:945–954.
1976. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pelletier CC, Koppe L, Croze ML, Kalbacher
E, Vella RE, Guebre-Egziabher F, Géloën A, Badet L, Fouque D and
Soulage CO: White adipose tissue overproduces the lipid-mobilizing
factor zinc alpha2-glycoprotein in chronic kidney disease. Kidney
Int. 83:878–886. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Pelletier CC, Koppe L, Alix PM, Kalbacher
E, Croze ML, Hadj-Aissa A, Fouque D, Guebre-Egziabher F and Soulage
CO: The relationship between renal function and plasma
concentration of the cachectic factor zinc-alpha2-glycoprotein
(ZAG) in adult patients with chronic kidney disease. PLoS One.
9:e1034752014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Robson KJ, Ooi JD, Holdsworth SR, Rossjohn
J and Kitching AR: HLA and kidney disease: From associations to
mechanisms. Nat Rev Nephrol. 14:636–655. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bouchara A, Yi D, Pastural M, Granjon S,
Selag JC, Laville M, Arkouche W, Pelletier S, Fouque D, Soulage CO
and Koppe L: Serum levels of the adipokine zinc-alpha2-glycoprotein
(ZAG) predict mortality in hemodialysis patients. Kidney Int.
94:983–992. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Matarese G and La Cava A: The intricate
interface between immune system and metabolism. Trends Immunol.
25:193–200. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Noh JY, Shin JU, Kim JH, Kim SH, Kim BM,
Kim YH, Park S, Kim TG, Shin KO, Park K and Lee KH: ZAG regulates
the skin barrier and immunity in atopic dermatitis. J Invest
Dermatol. 139:1648–1657. e16472019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Na HS, Kwon JE, Lee SH, Jhun J, Kim SM,
Kim SY, Kim EK, Jung K, Park SH and Cho ML: Th17 and IL-17 cause
acceleration of inflammation and fat loss by inducing
alpha2-glycoprotein 1 (AZGP1) in rheumatoid arthritis with high-fat
diet. Am J Pathol. 187:1049–1058. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yeregui E, Masip J, Viladés C, Domingo P,
Pacheco YM, Blanco J, Mallolas J, Alba V, Vargas M, García-Pardo G,
et al: Adipokines as new biomarkers of immune recovery: Apelin
receptor, RBP4 and ZAG are related to CD4(+) T-cell reconstitution
in PLHIV on suppressive antiretroviral therapy. Int J Mol Sci.
23:22022022. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Romauch M: Zinc-alpha2-glycoprotein as an
inhibitor of amine oxidase copper-containing 3. Open Biol.
10:1900352020. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Schmitt R, Marlier A and Cantley LG: Zag
expression during aging suppresses proliferation after kidney
injury. J Am Soc Nephrol. 19:2375–2383. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Sörensen-Zender I, Bhayana S, Susnik N,
Rolli V, Batkai S, Baisantry A, Bahram S, Sen P, Teng B, Lindner R,
et al: Zinc-alpha2-Glycoprotein exerts antifibrotic effects in
kidney and heart. J Am Soc Nephrol. 26:2659–2668. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
do Valle Duraes F, Lafont A, Beibel M,
Martin K, Darribat K, Cuttat R, Waldt A, Naumann U, Wieczorek G,
Gaulis S, et al: Immune cell landscaping reveals a protective role
for regulatory T cells during kidney injury and fibrosis. JCI
Insight. 5:e1306512020. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Adams EJ and Luoma AM: The adaptable major
histocompatibility complex (MHC) fold: Structure and function of
nonclassical and MHC class I-like molecules. Annu Rev Immunol.
31:529–561. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Takagaki M, Honke K, Tsukamoto T,
Higashiyama S, Taniguchi N, Makita A and Ohkubo I: Zn-alpha
2-glycoprotein is a novel adhesive protein. Biochem Biophys Res
Commun. 201:1339–1347. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Song Y, Huang X, Yu G, Qiao J, Cheng J, Wu
J and Chen J: Pathogenesis of IgA Vasculitis: An Up-to-date review.
Front Immunol. 12:7716192021. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Chimenti MS, Ballanti E, Triggianese P and
Perricone R: Vasculitides and the complement system: A
comprehensive review. Clin Rev Allergy Immunol. 49:333–346. 2015.
View Article : Google Scholar : PubMed/NCBI
|
